The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 Nephropathy
膳食营养素在慢性肾脏病进展和载脂蛋白 L1 肾病中的作用
基本信息
- 批准号:10608980
- 负责人:
- 金额:$ 18.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-15 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAfricaAfrica South of the SaharaAfricanAfrican American populationAmericanAnti-Inflammatory AgentsApolipoproteinsBiological MarkersBiometryBlack PopulationsBostonCareer ChoiceCessation of lifeChronic Kidney FailureCollectionData AnalysesDevelopmentDiabetes MellitusDialysis procedureDietDietary FactorsDietary FiberDietary PotassiumDietary PracticesDietary SodiumDietary intakeDiseaseDisease ProgressionElementsEnd stage renal failureEnvironmental ExposureEnvironmental Risk FactorEuropeExcretory functionFruitFundingGene ExpressionGenesGeneticGenetic RiskGenomicsGenotypeHealthHigh PrevalenceHumanIncidenceIndividualInflammasomeInflammationInflammatoryInheritedInjury to KidneyIntakeIntervention StudiesK-Series Research Career ProgramsKidneyKidney DiseasesKidney TransplantationLifeLife StyleLinkMaintenanceMalignant - descriptorMeasuresMinority GroupsModificationNational Institute of Diabetes and Digestive and Kidney DiseasesNutrientOutcomeOxalatesParentsParticipantPatientsPhenotypePopulationPotassiumProspective StudiesProspective, cohort studyPublic HealthRenal functionResearchResearch Project GrantsResourcesRiskRisk FactorsRisk ReductionRoleSodiumTestingToxic effectTrainingTransplantationUniversitiesUrineVariantVegetablesbiobankblood pressure elevationcareercostdesigndietarydisease phenotypedisorder riskearly onsetgene environment interactiongene interactiongenetic epidemiologygenetic risk factorglobal healthhealth determinantshealth disparityhigh riskmedical schoolsmitochondrial dysfunctionmodifiable risknephrotoxicitynew therapeutic targetnovelnutritionnutritional epidemiologypatient oriented researchprofessorprospectivepublic health researchrisk variantskill acquisitionskillsurinary
项目摘要
PROJECT SUMMARY/ABSTRACT
Chronic kidney disease (CKD)
individuals
Among
malignant Apolipoprotein L1 (APOL1).
Approximately 13% of African Americans and 25% of West Africans carry high risk renal genotypes,
comprising of any combination of the two APOL1 risk variants, G1 and G2.
This re-submission for a National Institute of Diabetes and Digestive Kidney Diseases Patient-Oriented
Research Career Development Award (K23) seeks to support Dr. Titilayo Ilori, an Assistant Professor at the
Boston University School of Medicine, who wants to build a career focused on mechanistic and interventional
studies on the effect of dietary factors and lifestyle on CKD incidence and progression in both low- and
adequately-resourced settings, especially in the context of genetic and genomic risk variants. Dr. Ilori's prior
research has focused on health disparities in CKD and secondary data analysis of nutrition-related exposures
and outcomes in kidney disease. Dr. Ilori intends to extend the scope of her research towards designing
prospective studies to study the role of dietary sodium and potassium in CKD progression and APOL1
Nephropathy in Africans. Accordingly, her K23 training is focused on acquiring skills in global health research,
nutritional and genetic epidemiology in CKD, statistical genetics and advanced biostatistics skills in longitudinal
data analysis, and biomarkers of CKD.
We propose a research project that leverages the Human Hereditary and Health in Africa Kidney Disease
Research Network and addresses the following research aims: 1) a cross-sectional and prospective
examination of the associations of dietary sodium, potassium, and oxalate intake – assessed through 24h urine
collections in Africans; 2) a cross-sectional and prospective study to determine the associations of dietary
patterns with CKD and CKD progression; 3) diet:gene interaction studies to examine whether dietary factors
(sodium, potassium, oxalate, or dietary patterns) modify the effect of association of APOL1 renal genotypes on
CKD progression. This is an important project because it may identify if dietary factors are modifiable risk
factors for CKD progressions in Africans in SSA, where the cost of dialysis and renal transplantation is
prohibitive. Additionally, evidence that diet alters the risk of nephropathy in those with high-risk APOL1 renal
risk alleles could be important in investigating new therapeutic targets for APOL1 Nephropathy.
is effectively a “death sentence” in Sub-Saharan Africa (SSA) where <2% of
with end stage renal disease (ESRD) have access to maintenance dialysis or transplantation.
Africans with CKD, there is a faster decline in kidney function and earlier onset of ESRD. This
CKD phenotype is largely attributable to variants in the gene encoding
项目摘要/摘要
慢性肾脏病(CKD)
个人
之中
恶性载脂蛋白L1(apol1)。
大约13%的非裔美国人和25%的西非人Cary高风险肾脏基因型,
包括两个APOL1风险变体G1和G2的任何组合。
这项重新提交了国家糖尿病和消化肾脏疾病的研究
研究职业发展奖(K23)旨在支持Titilayo Ilori博士,
波士顿大学医学院,他想建立专注于机械和国际的职业
研究饮食因素和生活方式对低 - 和低 - 和发展的影响的研究
足够的资源设置,尤其是在遗传和基因组风险变体的结合中
研究的重点是CKD中的健康差异和与营养有关的暴露的次要数据分析
肾脏疾病的结果。
前瞻性研究研究饮食钠和钾在CKD进展中的作用和APOL1
因此,非洲人的肾病。
CKD中的营养和遗传流行病学,统计遗传学和纵向的先进生物统计学技能
数据分析和CKD的生物标志物。
我们提出了一个研究项目,该项目利用非洲肾脏疾病的人类遗传和健康
研究网络并解决以下研究的目的:1)横断面和前置
检查饮食钠,钾和草酸盐摄入量的关联 - 通过24h尿液评估
非洲人的收集; 2)横断面和前瞻性研究
CKD和CKD进展的模式; 3)饮食:基因相互作用研究
(钠,钾,草酸盐或饮食模式)修改Apol1肾脏基因型关联对
CKD进展。这是一个重要的项目
透析和肾脏移植成本的SSA非洲人进行CKD进行的因素
另外,证据表明饮食在具有高风险apol1 renal1 renal1 renal1 renal1的肾病风险
风险等位基因在研究APOL1肾病的新疗法靶标可能很重要。
是撒哈拉以南非洲(SSA)的有效“死亡中心”,其中<2%
随着末期肾脏疾病(ESRD),可以使用维持透析或透明度。
具有CKD的非洲人,肾功能的下降速度更快,ESRD的发作更早
CKD表型更大,可归因于基因编码中的变体
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Titilayo Omolara Ilori其他文献
Titilayo Omolara Ilori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Titilayo Omolara Ilori', 18)}}的其他基金
The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 Nephropathy
膳食营养素在慢性肾脏病进展和载脂蛋白 L1 肾病中的作用
- 批准号:
10380175 - 财政年份:2020
- 资助金额:
$ 18.49万 - 项目类别:
The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 Nephropathy
膳食营养素在慢性肾脏病进展和载脂蛋白 L1 肾病中的作用
- 批准号:
10217120 - 财政年份:2020
- 资助金额:
$ 18.49万 - 项目类别:
The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 Nephropathy
膳食营养素在慢性肾脏病进展和载脂蛋白 L1 肾病中的作用
- 批准号:
10055616 - 财政年份:2020
- 资助金额:
$ 18.49万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
2/3 Akili: Phenotypic and genetic characterization of ADHD in Kenya and South Africa
2/3 Akili:肯尼亚和南非 ADHD 的表型和遗传特征
- 批准号:
10637187 - 财政年份:2023
- 资助金额:
$ 18.49万 - 项目类别:
1/3 Akili: Phenotypic and genetic characterization of ADHD in Kenya and South Africa
1/3 Akili:肯尼亚和南非 ADHD 的表型和遗传特征
- 批准号:
10633772 - 财政年份:2023
- 资助金额:
$ 18.49万 - 项目类别:
Clinical decision support algorithm to optimize management of respiratory tract infection in children attending primary health facilities in Kilimanjaro Region, Tanzania
用于优化坦桑尼亚乞力马扎罗地区初级卫生机构儿童呼吸道感染管理的临床决策支持算法
- 批准号:
10734148 - 财政年份:2023
- 资助金额:
$ 18.49万 - 项目类别:
Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
加强肯尼亚艾滋病毒阳性女性的宫颈癌筛查采用和治疗联系 (eCASCADE-Kenya)
- 批准号:
10738134 - 财政年份:2023
- 资助金额:
$ 18.49万 - 项目类别:
"Plasma and cellular immune biomarkers of Kaposi's sarcoma in HIV-1 suppressed patients"
“HIV-1 抑制患者中卡波西肉瘤的血浆和细胞免疫生物标志物”
- 批准号:
10871931 - 财政年份:2023
- 资助金额:
$ 18.49万 - 项目类别: